[Expression of regulatory T cells and related cytokines in mice allogenic corneal transplantation rejection]
- PMID: 20193436
[Expression of regulatory T cells and related cytokines in mice allogenic corneal transplantation rejection]
Abstract
Objective: To study the changes of CD4(+)CD25(+) and CD8(+)CD103(+) regulatory T cells and their relevant cytokines in corneal allograft transplantation in mice.
Methods: BABL/c (H-2(d)) mice received corneal allografts from C3H/He (H-2(k)) mice were served as the experimental group. BABL/c (H-2(d)) mice received corneal from BABL/c (H-2(d)) mice were used as the control group. Corneal graft survival time was recorded pre-, 3rd day, 7th day, 4th week, 8th week post-operatively. Infiltration of inflammatory cells and corneal neovascularization were evaluated by histopathologic examination. The percentage of CD4(+)CD25(+) and CD8(+)CD103(+) T cell in peripheral blood and spleen was determined by flow cytometry. The expression of interleukin-10 (IL-10), IL-4, gamma-interferon (IFN-gamma) and IL-1beta in serum and aqueous humor was measured by enzyme-linked immunospecific assay (ELISA).
Results: The graft rejection in experimental group occurred at 7 days to 4 weeks after the operation, averaged (14.79 +/- 1.02) days. The grafts in the control group remained clear within 8 weeks observation and the survival time is much longer than that of the allografts (chi(2) = 46.934, P = 0.000). Flow cytometry showed that the percentage of CD4(+)CD25(+) T cell in peripheral blood in the control group after surgery was (3.36 +/- 0.29)%, (4.09 +/- 0.44)%, (5.44 +/- 0.35)%, (5.73 +/- 0.53)% at day 3, day 7, 4th week, and 8th week, respectively, which was significantly higher than that in the experimental group [(2.50 +/- 0.39)%, (3.24 +/- 0.25)%, (4.20 +/- 0.45)%, (4.18 +/- 0.14)%; t = 3.828, 2.898, 3.780, 4.892; P < 0.05]. On the other hand, CD8(+)CD103(+) T cell in peripheral blood in the experimental group after surgery was (2.20 +/- 0.33)%, (2.79 +/- 0.57)%, (4.55 +/- 1.03)%, (4.31 +/- 0.07)% at different periods, which was much higher than that in the control group (t = 7.133, 4.876, 5.196, 19.960; P < 0.05). The changes of CD4(+)CD25(+) and CD8(+)CD103(+) T cells in the spleen was earlier than those in peripheral blood. ELISA showed the expression of IL-10 and IL-4 in the serum in experimental group after surgery was much lower than that in the control group (t = 3.203, 3.141, 3.012, 2.869 and 2.340, 6.681, 8.839, 8.574; P = 0.011, 0.012, 0.013, 0.019 and 0.053, 0.000, 0.000, 0.000). The serum levels of IFN-gamma and IL-1beta in experimental group were higher than that in the control group (t = 3.508, 3.265, 4.402, 5.539 and 3.630, 5.796, 1.728, 0.660; P = 0.006, 0.011, 0.002, 0.000 and 0.005, 0.000, 0.115, 0.524). Furthermore, the cytokine levels in the aqueous humor behaved similarly with those in the serum.
Conclusion: The down-regulation of CD4(+)CD25(+) Treg, IL-10 and IL-4 and the up-regulation of CD8(+)CD103(+) Treg, IFN-gamma and IL-1beta in mice allograft corneal rejection may play an important role in allograft rejection.
Similar articles
-
[Initial study on mechanism of a small non-peptidic CD4 inhibitor J2 in prevention corneal allograft rejection].Zhonghua Yan Ke Za Zhi. 2010 Jan;46(1):51-5. Zhonghua Yan Ke Za Zhi. 2010. PMID: 20388323 Chinese.
-
[CD4+CD25+ T cells involved in induction of rat corneal allograft immune tolerance].Zhonghua Yan Ke Za Zhi. 2007 Dec;43(12):1114-8. Zhonghua Yan Ke Za Zhi. 2007. PMID: 18331683 Chinese.
-
Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.Exp Clin Transplant. 2013 Feb;11(1):56-62. doi: 10.6002/ect.2012.0025. Epub 2012 Jul 5. Exp Clin Transplant. 2013. PMID: 22769982
-
Regulation of the CD4+ T cell allo-immune response by endothelial cells.Hum Immunol. 2012 Dec;73(12):1269-74. doi: 10.1016/j.humimm.2012.07.009. Epub 2012 Jul 16. Hum Immunol. 2012. PMID: 22813652 Review.
-
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis.Cytokine Growth Factor Rev. 2013 Feb;24(1):13-22. doi: 10.1016/j.cytogfr.2012.08.006. Epub 2012 Sep 13. Cytokine Growth Factor Rev. 2013. PMID: 22981349 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials